National Health (Originator Brand) Amendment Determination 2019 (No. 3) (PB 34 of 2019) (Cth)
PB 34 of 2019
National Health (Originator Brand) Amendment Determination 2019 (No. 3)
National Health Act 1953
I, SEAN LANE, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.
Dated 29 April 2019
SEAN LANE
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Name of Determination
(1) This Determination is the National Health (Originator Brand) Amendment Determination 2019 (No. 3).
(2) This Determination may also be cited as PB 34 of 2019.
Commencement
This Determination commences on 1 May 2019.
Amendments to PB 100 of 2015
Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).
Schedule 1 Amendments
(section 3)
[1] Schedule 1 (table item 16A)
Repeal the item:
| 16A | Apomorphine | Apomine Apomine Solution for Infusion |
Substitute:
| 16A | Apomorphine | Apomine Apomine Intermittent Apomine Solution for Infusion |
0
0
0